10100SJ0043 EngrossedLRB101 11737 MST 58399 r

1
SENATE JOINT RESOLUTION NO. 43
2
(As Amended by Senate Amendment No. 1)

 
3    WHEREAS, The human papillomavirus (HPV) is the most common
4sexually transmitted virus in the United States; nearly 14
5million people become infected each year; and
 
6    WHEREAS, HPV causes approximately 33,700 cases of
7HPV-associated cancers each year, including cervical, anal,
8and oropharyngeal cancers; and
 
9    WHEREAS, 9-valent HPV vaccine protects against nine types
10of HPV infection; and
 
11    WHEREAS, The HPV vaccine was tested before being licensed
12by the Food and Drug Administration and continues to be
13monitored by the Centers for Disease Control and Prevention and
14the Food and Drug Administration; and
 
15    WHEREAS, The most common side effects are mild and include
16pain, redness, or swelling in the arm where the shot is given;
17dizziness, fainting, nausea, and headaches can also occur; and
 
18    WHEREAS, The American Academy of Pediatrics (AAP) and the
19Advisory Committee on Immunization Practices (ACIP) recommend
20two doses of HPV vaccine for males and females ages 11-12; the

 

 

10100SJ0043 Engrossed- 2 -LRB101 11737 MST 58399 r

1vaccine is approved for men and women through age 45; and
 
2    WHEREAS, In Illinois, only 50 percent of males and females
3ages 13-17 years were up to date on HPV vaccination in 2017;
4therefore, be it
 
5    RESOLVED, BY THE SENATE OF THE ONE HUNDRED FIRST GENERAL
6ASSEMBLY OF THE STATE OF ILLINOIS, THE HOUSE OF REPRESENTATIVES
7CONCURRING HEREIN, that we encourage adolescents in Illinois to
8receive the HPV vaccine to protect themselves against HPV
9infection and HPV-related cancers.